Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rosenbaum

Showing results (401-410 of 471) with videos related to

Pageof 48
Sort By:
Ophthalmology|December 17, 2009
Hypopyon in patients with uveitisAli A Zaidi, Gui-Shuang Ying, Ebenezer Daniel, et al.
American Journal of Ophthalmology|January 1, 2010
Mycophenolate mofetil for ocular inflammationEbenezer Daniel, Jennifer E Thorne, Craig W Newcomb, et al.
American Journal of Ophthalmology|July 3, 2009
Azathioprine for ocular inflammatory diseasesSirichai Pasadhika, John H Kempen, Craig W Newcomb, et al.
American Journal of Ophthalmology|June 26, 2013
Risk of choroidal neovascularization among the uveitidesSally L Baxter, Maxwell Pistilli, Siddharth S Pujari, et al.
Ocular Immunology and Inflammation|March 14, 2012
High-dose intravenous corticosteroids for ocular inflammatory diseasesLeon D Charkoudian, Gui-shuang Ying, Siddharth S Pujari, et al.
Ophthalmology|August 5, 2009
Epidemiology and course of disease in childhood uveitisJanine A Smith, Friederike Mackensen, H Nida Sen, et al.
Ophthalmology|September 15, 2009
Methotrexate for ocular inflammatory diseasesSapna Gangaputra, Craig W Newcomb, Teresa L Liesegang, et al.
Ophthalmology|July 15, 2014
Periocular corticosteroid injections in uveitis: effects and complicationsH Nida Sen, Susan Vitale, Sapna S Gangaputra, et al.
Ophthalmology|April 10, 2012
Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseasesJoshua D Udoetuk, Yang Dai, Gui-Shuang Ying, et al.
The British Journal of Ophthalmology|February 5, 2013
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trialEric B Suhler, Careen Y Lowder, Debra A Goldstein, et al.
Pageof 48

Showing results (401-410 of 471) with videos related to

Sort By:
Pageof 48
Ophthalmology|December 17, 2009
Hypopyon in patients with uveitisAli A Zaidi, Gui-Shuang Ying, Ebenezer Daniel, et al.
American Journal of Ophthalmology|January 1, 2010
Mycophenolate mofetil for ocular inflammationEbenezer Daniel, Jennifer E Thorne, Craig W Newcomb, et al.
American Journal of Ophthalmology|July 3, 2009
Azathioprine for ocular inflammatory diseasesSirichai Pasadhika, John H Kempen, Craig W Newcomb, et al.
American Journal of Ophthalmology|June 26, 2013
Risk of choroidal neovascularization among the uveitidesSally L Baxter, Maxwell Pistilli, Siddharth S Pujari, et al.
Ocular Immunology and Inflammation|March 14, 2012
High-dose intravenous corticosteroids for ocular inflammatory diseasesLeon D Charkoudian, Gui-shuang Ying, Siddharth S Pujari, et al.
Ophthalmology|August 5, 2009
Epidemiology and course of disease in childhood uveitisJanine A Smith, Friederike Mackensen, H Nida Sen, et al.
Ophthalmology|September 15, 2009
Methotrexate for ocular inflammatory diseasesSapna Gangaputra, Craig W Newcomb, Teresa L Liesegang, et al.
Ophthalmology|July 15, 2014
Periocular corticosteroid injections in uveitis: effects and complicationsH Nida Sen, Susan Vitale, Sapna S Gangaputra, et al.
Ophthalmology|April 10, 2012
Risk of corticosteroid-induced hyperglycemia requiring medical therapy among patients with inflammatory eye diseasesJoshua D Udoetuk, Yang Dai, Gui-Shuang Ying, et al.
The British Journal of Ophthalmology|February 5, 2013
Adalimumab therapy for refractory uveitis: results of a multicentre, open-label, prospective trialEric B Suhler, Careen Y Lowder, Debra A Goldstein, et al.
Pageof 48